Sanofi Genzyme Launches its vs.MS Global Campaign to Address the Physical and Emotional Burden of Multiple Sclerosis

[Business Wire] – Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today the launch of vs.MS, a global initiative focused on highlighting and addressing the sometimes debilitating symptoms that accompany MS, as well as their daily impact on people living with and affected by the disease.